维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Brotchie JM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Levodopa induced dyskinesia in Parkinson' s disease显示文摘	Brotchie JM Lee J Venderova K	2005	J Neural Transm2005，112，：	1
2	Serotonin and Parkinson's disease: on movement, mood, and madness显示文摘	Fox SH Chuang R Brotchie JM	2009	Mov Disord2009，24，：	1
3	Characterization of enhanced behavioral responses to L-dopa following repeated administration in the 6-hydroxydopamine lesioned rat model of Parkinson's disease显示文摘	Henry B Crossman AR Brotchie JM	1998	Exp Neurol1998，151，2：	1
4	Pathophysiology of levodopa induced dyskinesia: potential for new therapies 显示文摘	Bezard E Brotchie JM Gross CE	2001	Nat Rev Neurosci2001，2，：	1
5	Levodopa- induced dyskinesias显示文摘	Fabbrini G Brotchie JM Grandas F	2007	Mov Disord2007，22，：	1
6	Effects of opioid antagonists on LDOPA - induced dyskinesia in Parkin- son' s disease 显示文摘	Fox SH Johnston TH Brotchie JM	2009	Humana Press2009，，：	1
7	Levodopa-induced Dyskinesia in Parkinson' S Disease显示文摘	BROTCHIE JM LEE J VENDEROVA K	2005	J Neural Transm(S0300 - 9564)2005，112，：	1
8	Differential effects of endocannabinoids on-GABA uptake in the rat globus pallidus显示文摘	Venderova K Brown TM Brotchie JM	2005	Exp Neurol2005，194，：	1
9	Drugs in development for Parkinsen's disease:an update 显示文摘	Johnston TH Brotchie JM	2006	Curt Opin Investig Drugs2006，7，1：	1
10	Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson 's disease 显示文摘	Henry B Crossman AR Brotchie JM	1998	Exp Neurol1998，151，：	1
11	Pathophysiology of levodopa-induced dyskinesia:potential for new therapies显示文摘	Bezard E Brotchie JM Gross CE	2001	Nat Rev Neurosci2001，2，8：	1
12	Levodopa-induced dyskinesias 显示文摘	Fabbrini G Brotchie JM Grandas F	2007	Mov Disord2007，22，10：	1
13	The adrenergic receptor agonist, clonidine,potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine depleted rat 显示文摘	HILL MP BROTCHIE JM	1999	Br J Pharmacol1999，128，7：	1
14	Drugs in development for Parkinson'sdisease显示文摘	JohnstonTH Brotchie JM	2004	Curr Opin-Investig Drugs2004，5，7：	1
15	Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials 显示文摘	Kalia LV Brotchie JM Fox SH	2013	Mov Disord2013，28，2：	1
16	Effect of repeated L- DOPA, bromocriptine, or lisuride administration on prepro enphalin- A and preproenkephalin-B mRNA levels in the stria- turn of the 6-hydroxydopamine-lesioned rat显示文摘	Hemy B Crossman AR Brotchie JM	1999	Exp Neurol1999，155，2：	1
17	Levodopa-induced dyskinesia in Parkinson's disease显示文摘	Brotchie JM Lee J Venderova K	2005	J Neural Transm2005，112，3：	1
18	Characterisation of striatal NMDA receptors involved in the generation ofparkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat 显示文摘	Nash JE Brotchie JM	2002	Mov Disord2002，17，3：	1
19	Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease显示文摘	Henry B Crossman AR Brotchie JM	1998	Exp Neurol1998，151，：	1
20	The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease显示文摘	Huot P Johnston TH Brotchie JM	2013	Pharmacol Rev2013，65，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示